Clinical trial
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
NCT07693608
Study timeline
Study start (actual)2026-08-19Date precision: day
Registry last updated2026-08-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesityunresolved
Methamphetamine Use Disorderunresolved
Cocaine Use Disorderunresolved
Stimulant Use Disordersunresolved
Interventions
TirzepatideDRUG · verified · RxNorm: tirzepatide
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07693608 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.